Monte Rosa Therapeutics (GLUE) Treasury Shares: 2023-2025
Historic Treasury Shares for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $774,675.
- Monte Rosa Therapeutics' Treasury Shares rose 590.69% to $774,675 in Q3 2025 from the same period last year, while for Sep 2025 it was $774,675, marking a year-over-year increase of 590.69%. This contributed to the annual value of $112,159 for FY2024, which is 52.58% down from last year.
- Per Monte Rosa Therapeutics' latest filing, its Treasury Shares stood at $774,675 for Q3 2025, which was down 0.34% from $777,325 recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Treasury Shares registered a high of $894,334 during Q1 2025, and its lowest value of $91,000 during Q1 2023.
- Over the past 3 years, Monte Rosa Therapeutics' median Treasury Shares value was $236,519 (recorded in 2024), while the average stood at $357,496.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Treasury Shares slumped by 55.18% in 2024, and later spiked by 590.69% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Treasury Shares (Quarterly) stood at $236,519 in 2023, then tumbled by 52.58% to $112,159 in 2024, then soared by 590.69% to $774,675 in 2025.
- Its last three reported values are $774,675 in Q3 2025, $777,325 for Q2 2025, and $894,334 during Q1 2025.